NeuroSigma
NeuroSigma develops and commercializes trigeminal nerve stimulation (TNS) for a variety of neurologic and psychiatric disorders.
NeuroSigma is active in the biotechnology, developer platform, medical space based in Greater Los Angeles Area, West Coast, Western US, founded in 2008.
The company sits in the biotechnology, developer platform, medical segment, where it competes on its core product or service.
Greater Los Angeles Area, West Coast, Western US is where the company is located.
It is recorded at the Corporate_Round stage.
Recorded headcount: c_00011_00050 employees.
Total disclosed funding stands at about $18.4M.
| Sector | Biotechnology, Developer Platform, Medical |
|---|---|
| Headquarters | Greater Los Angeles Area, West Coast, Western US |
| Country | US |
| Founded | 2008 |
| Employees | c_00011_00050 |
| Stage | corporate_round |
| Total funding | $18,363,514 |
Website: neurosigma.com
Browse related
Sign in to view the contact information we hold for NeuroSigma.
Create a free account
Create a free account